MedTrace Logo

Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease

NCT01458158 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2015-02-23

No results posted yet for this study

Summary

The purpose of this study is to determine whether matrix metalloproteinases are associated with atherosclerosis in the different stages of chronic kidney disease.

Conditions

  • Diabetic Nephropathy

Sponsors & Collaborators

  • AHEPA University Hospital

    collaborator OTHER

  • Aristotle University Of Thessaloniki

    lead OTHER

Principal Investigators

  • Grigorios G. Dimas, MD · AHEPA University Hospital,Medical School of Aristotle University of Thessaloniki

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01458158 on ClinicalTrials.gov